# Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

> **NCT02408159** · PHASE4 · TERMINATED · sponsor: **Innovaderm Research Inc.** · enrollment: 3 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** Varicella Zoster Vaccine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02408159
- **Lead sponsor:** Innovaderm Research Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2017-01
- **Final completion:** 2017-03
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Recruitment difficulties
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408159, "Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02408159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*